Discovery and SAR studies of novel 2-anilinopyrimidine-based selective inhibitors against triple-negative breast cancer cell line MDA-MB-468
Jeyun Jo(Pusan National University), Hwayoung Yun(University of Toronto), Young‐Suk Jung(Pusan National University), Heegyu Kim(Pusan National University), Jee‐Yeong Jeong(Beth Israel Deaconess Medical Center), Sou Hyun Kim(Pusan National University), Jae‐Hwan Kwak(Kyungsung University), Myeonggyo Jeong(Pusan National University), Young Taek Han(Dankook University)
Cited by 14
Related Papers
Design, Synthesis, and Biological Evaluation of Novel Deguelin-Based Heat Shock Protein 90 (HSP90) Inhibitors Targeting Proliferation and Angiogenesis
|Journal of Medicinal Chemistry|2012|102
Recent Advances in the Synthesis of Biologically Active Cinnoline, Phthalazine and Quinoxaline Derivatives
|Current Organic Chemistry|2017|70
Pyrazole-5-carboxamides, novel inhibitors of receptor for advanced glycation end products (RAGE)
|European Journal of Medicinal Chemistry|2014|65
Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells
|International Journal of Cancer|2007|59